IRON Disc Medicine, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 30, 2026
$64,51
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$55,5152 haftanın en düşüğü
$99,5052 haftanın en yükseği
Piyasa Değeri (MRQ)
$2.47B
P/E
-10.7
Hisse Başına Kâr
$-6.01
rozetleriniz
52 Haftlık Aralık
$56–$100
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$103
P/E
-10.7
ROE
-31.3%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
IRON Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$64.51
Piyasa Değeri (MRQ)
$2.47B
P/E
-10.7
Hisse Başına Kâr
$-6.01
ROE
-31.3%
52 Haftlık Aralık
$56–$100
IRON Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 30 Aralık 2022 | 1-for-30 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-6.012021-12-31 → 2025-12-31
Serbest Nakit Akışı$-181M2021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | IRON | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -10.75Y ort. ≈-9.7 | ≈-9.7 | · | · | |
| F/D (MRQ) | 3.85Y ort. ≈8.9 | ≈8.9 | 4.6 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -12.55Y ort. ≈-25.4 | ≈-25.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -12.55Y ort. ≈-25.5 | ≈-25.5 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.35Y ort. ≈3.6 | ≈3.6 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | IRON | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -32.6%5Y ort. ≈-42.7% | ≈-42.7% | -39.0% | En üst düzey | |
| ROE | -31.3%5Y ort. ≈-50.2% | ≈-50.2% | -47.0% | En üst düzey | |
| ROIC | -32.0%5Y ort. ≈-29.2% | ≈-29.2% | -35.9% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | IRON | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 24.15Y ort. ≈15.7 | ≈15.7 | 14.6 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 21.65Y ort. ≈15.4 | ≈15.4 | 11.7 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.2%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-1.54 | $-1.78 | 13.6% |
| 31 Mart 2026 | May 7, 2026 | $-1.65 | $-1.75 | 5.6% |
| 31 Aralık 2025 | $-1.64 | $-1.78 | 7.8% | |
| 30 Eylül 2025 | $-1.77 | $-1.49 | -18.6% | |
| 30 Haziran 2025 | $-1.58 | $-1.18 | -33.6% | |
| 31 Mart 2025 | $-1.02 | $-1.16 | 11.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $171M | $97M | $69M | $33M | $25M | $28M | |
| SG&A Expense | $65M | $33M | $22M | $14M | $6M | $6M | |
| Operating Expenses | $236M | $130M | $91M | $47M | $31M | $34M | |
| Operating Income | $-236M | $-130M | $-91M | $-47M | $-31M | $-34M | |
| Interest Expense | · | · | · | · | $2M | $7M | |
| Other Non-op | $45.0K | $-2.0K | $-2.0K | $0 | $-5M | · | |
| Pretax Income | $-212M | $-109M | $-76M | $-47M | · | · | |
| Income Tax | $361.0K | $355.0K | $99.0K | $0 | · | · | |
| Net Income | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| EPS (Basic) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| EPS (Diluted) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| Shares (Basic) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| Shares (Diluted) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| EBITDA | $-236M | $-130M | $-91M | $-47M | $-69M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $192M | $360M | $195M | $88M | $5M | |
| Short-term Investments | $700M | $297M | $0 | · | · | · | |
| Prepaid Expense | $13M | $4M | $5M | $4M | $2M | $562.0K | |
| Current Assets | $804M | $494M | $366M | $198M | $90M | $5M | |
| PP&E (Net) | $1M | $751.0K | $170.0K | $168.0K | $106.0K | $294.0K | |
| PP&E (Gross) | · | · | · | · | $0 | $955.0K | |
| Accum. Depreciation | · | $401.0K | $245.0K | $145.0K | $56.0K | $661.0K | |
| Other Non-current Assets | $726.0K | $838.0K | $234.0K | $116.0K | $180.0K | · | |
| Total Assets | $807M | $497M | $368M | $200M | $92M | $8M | |
| Accounts Payable | $9M | $8M | $13M | $16M | $3M | $2M | |
| Accrued Liabilities | $16M | $8M | $6M | $6M | $4M | $492.6K | |
| Current Liabilities | $37M | $23M | $21M | $23M | $13M | $25M | |
| Capital Leases | $1M | $2M | $1M | $1M | $1M | · | |
| Total Liabilities | $67M | $53M | $23M | $24M | $15M | $30M | |
| Long-term Debt | $29M | $28M | $0 | · | · | $14M | |
| Common Stock | $4.0K | $3.0K | $2.0K | $2.0K | $0 | $2.0K | |
| Paid-in Capital | $1.25B | $741M | $534M | $289M | $1M | $91M | |
| Retained Earnings | $-510M | $-298M | $-189M | $-112M | $-65M | $-113M | |
| AOCI | $965.0K | $289.0K | $0 | · | · | · | |
| Stockholders' Equity | $740M | $444M | $345M | $177M | $-64M | $-29M | |
| Liabilities + Equity | $807M | $497M | $368M | $200M | $92M | $8M | |
| Shares Outstanding | 37,890,616 | 29,865,030 | 24,360,233 | 17,403,315 | 909,418 | 15,565,380 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $281.0K | $156.0K | $100.0K | $89.0K | $32.0K | · | |
| Stock-based Comp | $34M | $17M | $6M | $2M | $507.0K | $983.0K | |
| Deferred Tax | $0 | · | · | · | · | · | |
| Other Non-cash | $-3M | $-2M | $-3M | $2M | · | · | |
| Operating Cash Flow | $-180M | $-94M | $-73M | $-42M | $-28M | $-33M | |
| CapEx | $933.0K | $505.0K | $89.0K | $151.0K | $68.0K | $22.0K | |
| Investing Cash Flow | $-394M | $-292M | $-89.0K | $-151.0K | $-68.0K | $-22.0K | |
| Debt Issued | $0 | $29M | $0 | · | · | · | |
| Net Debt Issued | $0 | $29M | · | · | · | · | |
| Stock Issued | · | · | $0 | $54M | $0 | $20M | |
| Net Stock Activity | · | · | $0 | $54M | $0 | · | |
| Financing Cash Flow | $473M | $218M | $239M | $149M | $90M | $34M | |
| Net Change in Cash | $-101M | $-168M | $166M | $107M | $62M | $2M | |
| Taxes Paid | $349.0K | $300.0K | $100.0K | $0 | $0 | · | |
| Free Cash Flow | $-181M | $-94M | $-74M | $-42M | $-60M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -32.6% | -25.3% | -26.9% | -32.0% | -96.6% | · | |
| ROE | -31.3% | -24.0% | -21.7% | -120.0% | -54.1% | · | |
| ROIC | -32.0% | -29.3% | -26.4% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 | 2.2 | |
| Quick Ratio | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 | 2.0 | |
| Interest Coverage | · | · | · | · | -32.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.53 | $14.85 | $14.17 | $10.15 | $2.89 | · | |
| Cash Flow / Share | $-5.11 | $-3.40 | $-3.29 | $-40.65 | · | · | |
| Cash / Share | $2.41 | $6.44 | $14.79 | $11.18 | $3.16 | · | |
| EPS (TTM) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| Market Cap | $3.01B | $1.89B | $1.41B | $346M | $3.77B | · | |
| P/E | -13.2 | -16.0 | -16.9 | -0.4 | -2.1 | · | |
| P/B | 4.1 | 4.3 | 4.1 | 2.0 | 30.2 | · | |
| P / Tangible Book | 4.1 | 4.3 | 4.1 | 2.0 | · | · | |
| P / Cash Flow | -16.7 | -20.2 | -19.2 | -8.2 | -63.2 | · | |
| P / FCF | -16.6 | -20.1 | -19.1 | -8.2 | -63.1 | · | |
| Earnings Yield | -7.6% | -6.2% | -5.9% | -226.5% | -46.9% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $46M | $46M | $50M | $46M | $28M | $25M | $25M | $23M | $24M | $14M | $12M | $20M | $10M | $8M | $8M | |
| SG&A Expense | $18M | $24M | $21M | $17M | $15M | $12M | $10M | $8M | $7M | $8M | $5M | $5M | $5M | $5M | $3M | $4M | |
| Operating Expenses | $65M | $70M | $67M | $68M | $61M | $40M | $35M | $33M | $31M | $31M | $19M | $17M | $25M | $15M | $10M | $12M | |
| Operating Income | $-65M | $-70M | $-67M | $-68M | $-61M | $-40M | $-35M | $-33M | $-31M | $-31M | $-19M | $-17M | $-25M | $-15M | $-10M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41.0K | $48.0K | |
| Other Non-op | $-12.0K | $22.0K | $-2.0K | $-18.0K | $68.0K | $-3.0K | $3.0K | $9.0K | $-13.0K | $-1.0K | $13.0K | $-5.0K | $0 | $-107.0K | $0 | $0 | |
| Pretax Income | $-59M | $-63M | $-60M | $-62M | $-55M | $-34M | $-29M | $-26M | $-26M | $-27M | $-14M | $-16M | $-23M | $-11M | $-16M | $-10M | |
| Income Tax | $69.0K | $51.0K | $88.0K | $102.0K | $52.0K | $119.0K | $176.0K | $114.0K | $60.0K | $5.0K | $20.0K | $24.0K | $23.0K | $0 | $0 | $0 | |
| Net Income | $-60M | $-64M | $-61M | $-62M | $-55M | $-34M | $-29M | $-27M | $-26M | $-27M | $-14M | $-16M | $-23M | $-11M | $-16M | $-10M | |
| EPS (Basic) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | $-10.14 | |
| EPS (Diluted) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | $-10.14 | |
| Shares (Basic) | 38,685,565 | 38,491,433 | · | 35,178,691 | 35,024,592 | 33,324,745 | · | 29,935,551 | 25,649,043 | 24,809,869 | 24,316,817 | 21,484,955 | 18,954,914 | · | 960,317 | 944,706 | |
| Shares (Diluted) | 38,685,565 | 38,491,433 | · | 35,178,691 | 35,024,592 | 33,324,745 | · | 29,935,551 | 25,649,043 | 24,809,869 | 24,316,817 | 21,484,955 | 18,954,914 | · | 960,317 | 944,706 | |
| EBITDA | $-65M | $-69M | · | $-68M | $-61M | $-40M | · | $-33M | $-31M | $-31M | $-19M | $-17M | $-25M | · | $-4M | $-7M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $89M | $91M | $141M | $127M | $123M | $192M | $193M | $281M | $343M | $371M | $378M | $236M | $195M | $102M | $109M | |
| Short-term Investments | $619M | $641M | $700M | $475M | $523M | $572M | $297M | $295M | $220M | · | · | · | · | · | · | · | |
| Prepaid Expense | $15M | $17M | $13M | $11M | $12M | $11M | $4M | $6M | $7M | $9M | $4M | $4M | $6M | $4M | $3M | $4M | |
| Current Assets | $733M | $747M | $804M | $627M | $662M | $706M | $494M | $493M | $508M | $352M | $374M | $382M | $242M | $198M | $105M | $113M | |
| PP&E (Net) | $980.0K | $1M | $1M | $1M | $1M | $1M | $751.0K | $79.0K | $98.0K | $211.0K | $183.0K | $159.0K | $180.0K | $168.0K | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | $392.0K | $381.0K | $271.0K | $220.0K | $195.0K | $170.0K | $145.0K | · | · | |
| Other Non-current Assets | $496.0K | $721.0K | $726.0K | $840.0K | $840.0K | $839.0K | $838.0K | $236.0K | $236.0K | $235.0K | $116.0K | $116.0K | $116.0K | $116.0K | $1M | $204.0K | |
| Total Assets | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | $376M | $384M | $244M | $200M | $106M | $113M | |
| Accounts Payable | $7M | $12M | $9M | $7M | $6M | $7M | $8M | $4M | $5M | $5M | $8M | $5M | $6M | $16M | $1M | $2M | |
| Accrued Liabilities | $9M | $7M | $16M | $11M | $6M | $4M | $8M | $6M | $4M | $9M | $6M | $4M | $4M | $6M | · | · | |
| Current Liabilities | $30M | $31M | $37M | $27M | $21M | $19M | $23M | $25M | $20M | $15M | $14M | $10M | $10M | $23M | $1M | $6M | |
| Capital Leases | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $945.0K | $1M | · | · | |
| Total Liabilities | $91M | $62M | $67M | $57M | $51M | $49M | $53M | $27M | $21M | $16M | $18M | $13M | $11M | $24M | $1M | $6M | |
| Long-term Debt | $59M | $29M | $29M | $29M | $29M | $29M | $28M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $4.0K | |
| Paid-in Capital | $1.28B | $1.26B | $1.25B | $1.02B | $1.00B | $992M | $741M | $736M | $731M | $554M | $524M | $522M | $368M | $289M | $315M | $314M | |
| Retained Earnings | $-633M | $-574M | $-510M | $-450M | $-387M | $-332M | $-298M | $-269M | $-242M | $-216M | $-165M | $-151M | $-135M | $-112M | $-210M | $-207M | |
| AOCI | $-2M | $-571.0K | $965.0K | $718.0K | $273.0K | $535.0K | $289.0K | $741.0K | $-60.0K | · | · | · | · | · | · | · | |
| Stockholders' Equity | $644M | $688M | $740M | $573M | $614M | $660M | $444M | $468M | $489M | $338M | $359M | $371M | $233M | $177M | $105M | $107M | |
| Liabilities + Equity | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | $376M | $384M | $244M | $200M | $106M | $113M | |
| Shares Outstanding | 38,345,666 | 38,190,464 | 37,890,616 | 35,006,636 | 34,694,882 | 34,581,222 | 29,865,030 | 29,748,154 | 29,707,997 | 24,695,885 | 24,139,078 | 22,850,894 | 19,575,242 | 17,403,315 | 43,299,453 | 43,244,453 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $89.0K | $89.0K | $87.0K | $85.0K | $20.0K | $9.0K | $11.0K | $110.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $24.0K | $22.0K | |
| Stock-based Comp | $14M | $12M | $10M | $10M | $8M | $6M | $4M | $4M | $4M | $4M | $1M | $1M | $1M | $993.0K | $-3M | $-1M | |
| Other Non-cash | · | $-11M | · | · | · | $-14M | · | · | · | $-11M | · | · | $-14M | · | · | · | |
| Operating Cash Flow | $-44M | $-62M | $-43M | $-48M | $-48M | $-41M | $-28M | $-17M | $-15M | $-34M | $-7M | $-13M | $-35M | $-10M | $-7M | $-7M | |
| CapEx | $0 | $0 | $20.0K | $26.0K | $36.0K | $851.0K | $449.0K | $-8.0K | $-3.0K | $67.0K | $45.0K | $12.0K | $29.0K | $12.0K | $19.0K | $20.0K | |
| Investing Cash Flow | $22M | $58M | $-223M | $50M | $52M | $-273M | $-1M | $-71M | $-220M | $-67.0K | $-45.0K | $-12.0K | $-29.0K | $-12.0K | $-19.0K | $-20.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | · | |
| Financing Cash Flow | $32M | $2M | $217M | $12M | $892.0K | $244M | $29M | $426.0K | $173M | $16M | $460.0K | $154M | $77M | $149M | $3M | $1M | |
| Net Change in Cash | $10M | $-2M | $-50M | $13M | $5M | $-70M | $-202.0K | $-88M | $-62M | $-18M | $-7M | $141M | $42M | $139M | $-4M | $-5M | |
| Taxes Paid | · | · | · | · | · | · | $263.0K | $4.0K | $33.0K | $0 | $78.0K | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | $-62M | · | · | · | $-42M | · | · | · | $-34M | · | · | $-35M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.5% | -8.7% | · | -11.1% | -9.4% | -6.4% | · | -6.1% | -5.9% | -9.0% | -5.9% | -6.4% | -12.4% | · | -2.5% | -5.0% | |
| ROE | -9.5% | -9.4% | · | -12.0% | -10.0% | -6.8% | · | -6.4% | -6.1% | -9.4% | -6.1% | -6.7% | -13.2% | · | -2.7% | -5.4% | |
| ROIC | -10.1% | -10.1% | · | -11.8% | -10.0% | -6.1% | · | -7.0% | -6.3% | -9.3% | -5.3% | -4.7% | -10.8% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.1 | 24.0 | · | 23.5 | 32.1 | 37.7 | · | 19.4 | 25.0 | 23.7 | 26.0 | 39.4 | 24.3 | · | 71.5 | 17.6 | |
| Quick Ratio | 23.6 | 23.4 | · | 23.0 | 31.5 | 37.1 | · | 19.1 | 24.7 | 23.1 | 25.7 | 39.0 | 23.7 | · | 69.5 | 16.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -91.1 | -150.7 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.80 | $18.03 | · | $16.38 | $17.70 | $19.10 | · | $15.73 | $16.45 | $13.69 | $14.87 | $16.25 | $11.90 | · | $2.42 | $2.47 | |
| Cash Flow / Share | · | $-1.62 | · | · | · | $-1.24 | · | · | · | $-1.35 | · | · | $-1.87 | · | · | · | |
| Cash / Share | $2.57 | $2.33 | · | $4.02 | $3.67 | $3.55 | · | $6.48 | $9.45 | $13.87 | $15.35 | $16.52 | $12.08 | · | $2.35 | $2.51 | |
| EPS (TTM) | $-6.60 | $-6.64 | · | $-5.32 | $-4.44 | $-3.89 | · | $-3.91 | $-3.60 | $-3.31 | $-9.94 | $-26.18 | $-35.58 | · | $-77.21 | $-60.82 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-246M | $-242M | · | $-181M | $-145M | $-116M | · | $-103M | $-91M | $-81M | $-64M | $-66M | $-60M | · | $-18M | $-20M | |
| Market Cap | $2.80B | $2.44B | · | $2.31B | $1.84B | $1.72B | · | $1.46B | $1.34B | $1.54B | $1.13B | $1.01B | $415M | · | $2.13B | $2.19B | |
| P/E | -11.1 | -9.6 | · | -12.4 | -11.9 | -12.8 | · | -12.6 | -12.5 | -18.8 | -4.7 | -1.7 | -0.6 | · | -0.6 | -0.8 | |
| P/B | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | 3.2 | 2.7 | 1.8 | · | 20.4 | 20.5 | |
| P / Tangible Book | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | 3.2 | 2.7 | 1.8 | · | 20.4 | 20.5 | |
| P / Cash Flow | · | -39.2 | · | · | · | -41.5 | · | · | · | -45.8 | · | · | -11.7 | · | · | · | |
| Earnings Yield | -9.0% | -10.4% | · | -8.1% | -8.4% | -7.8% | · | -8.0% | -8.0% | -5.3% | -21.2% | -59.0% | -167.9% | · | -156.9% | -120.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-212M | $-109M | $-76M | $-47M | $-36M |
| Seyreltilmiş Hisse Başı Kâr | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 |
| Cari Oran | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-181M | $-94M | $-74M | $-42M | $-60M |
Kurumsal Sahipler (13F) 236 dosya · $3.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
236
Tutulan Değer
$3.1B
Yeni pozisyonlar
44
Çıkan pozisyonlar
22
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 44 (-11 önceki Ç'ye göre) | 22 (-15 önceki Ç'ye göre) | 77 (-5 önceki Ç'ye göre) | 66 (+24 önceki Ç'ye göre) | +795K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $357.981.753 | 4.894.473 | 11,37% | Hisse senetleri |
| BlackRock, Inc. | $180.502.133 | 2.467.899 | 5,73% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $179.209.164 | 2.450.221 | 5,69% | Hisse senetleri |
| VANGUARD GROUP INC | $140.371.470 | 1.767.680 | 4,46% | Hisse senetleri |
| JPMORGAN CHASE & CO | $139.868.053 | 1.875.795 | 4,44% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $127.362.413 | 1.741.351 | 4,05% | Hisse senetleri |
| STATE STREET CORP | $120.595.865 | 1.648.836 | 3,83% | Hisse senetleri |
| Vestal Point Capital, LP | $113.367.000 | 1.550.000 | 3,60% | Hisse senetleri |
| Atlas Venture Life Science Advisors, LLC | $110.724.818 | 1.513.875 | 3,52% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.130.635 | 1.369.027 | 3,18% | Hisse senetleri |
| Frazier Life Sciences Management, L.P. | $99.093.875 | 1.354.852 | 3,15% | Hisse senetleri |
| TCG Crossover Management, LLC | $98.143.787 | 1.341.862 | 3,12% | Hisse senetleri |
| BVF INC/IL | $84.375.182 | 1.153.612 | 2,68% | Hisse senetleri |
| Woodline Partners LP | $70.088.672 | 958.281 | 2,23% | Hisse senetleri |
| Siren, L.L.C. | $64.977.649 | 888.401 | 2,06% | Hisse senetleri |
| Logos Global Management LP | $63.997.500 | 875.000 | 2,03% | Hisse senetleri |
| Opaleye Management Inc. | $62.534.700 | 855.000 | 1,99% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $57.772.342 | 789.724 | 1,84% | Hisse senetleri |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $48.052.980 | 657.000 | 1,53% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $41.622.451 | 569.018 | 1,32% | Hisse senetleri |
| Bellevue Group AG | $40.958.400 | 560.000 | 1,30% | Hisse senetleri |
| Saturn V Capital Management LP | $38.378.752 | 524.730 | 1,22% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $33.644.400 | 460.000 | 1,07% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $32.146.492 | 439.520 | 1,02% | Hisse senetleri |
| Aberdeen Group plc | $32.048.046 | 438.174 | 1,02% | Hisse senetleri |
| Palo Alto Investors LP | $30.473.488 | 416.646 | 0,97% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $28.938.480 | 395.651 | 0,92% | Hisse senetleri |
| Pictet Asset Management Holding SA | $28.186.328 | 385.375 | 0,90% | Hisse senetleri |
| Assenagon Asset Management S.A. | $28.097.316 | 384.158 | 0,89% | Hisse senetleri |
| LOOMIS SAYLES & CO L P | $27.929.533 | 381.864 | 0,89% | Hisse senetleri |
| Foresite Capital Management V, LLC | $27.359.407 | 374.069 | 0,87% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $26.150.110 | 357.535 | 0,83% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $25.573.913 | 349.657 | 0,81% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.620.872 | 281.937 | 0,66% | Hisse senetleri |
| Octagon Capital Advisors LP | $19.747.800 | 270.000 | 0,63% | Hisse senetleri |
| NORTHERN TRUST CORP | $19.381.368 | 264.990 | 0,62% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.824.919 | 257.382 | 0,60% | Hisse senetleri |
| Checkpoint Capital L.P. | $17.562.743 | 240.125 | 0,56% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $16.470.982 | 225.198 | 0,52% | Hisse senetleri |
| CITADEL ADVISORS LLC | $15.308.787 | 209.308 | 0,49% | Hisse senetleri |
| Bank of New York Mellon Corp | $14.973.763 | 204.727 | 0,48% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $13.508.592 | 184.695 | 0,43% | Hisse senetleri |
| Catalio Capital Management, LP | $11.657.346 | 159.384 | 0,37% | Hisse senetleri |
| Caption Management, LLC | $10.971.000 | 150.000 | 0,35% | Alım opsiyonu |
| Sofinnova Investments, Inc. | $10.695.920 | 146.239 | 0,34% | Hisse senetleri |
| Bain Capital Life Sciences Investors, LLC | $10.329.855 | 141.234 | 0,33% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $10.001.895 | 136.750 | 0,32% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $9.882.018 | 135.111 | 0,31% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $9.142.500 | 125.000 | 0,29% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $8.931.199 | 122.111 | 0,28% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC ×6 başvurular | 17 Aralık 2025 | 2,20% | Değişiklik | · | SEC |
| AI DMI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×7 başvurular | 22 Ekim 2025 | 8,00% | Değişiklik | M&A / satış | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC ×6 başvurular | 12 Mart 2025 | 4,50% | Değişiklik | · | SEC |
| Adage Capital Partners, L.P., Adage Capital Partners GP, L.L.C., Adage Capital Advisors, L.L.C., Robert Atchinson, Phillip Gross ×3 başvurular | 16 Şubat 2023 | · | İlk başvuru | · | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Singapore, L.P., Lightstone Singapore Associates, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×2 başvurular | 14 Şubat 2023 | · | İlk başvuru | M&A / satış | SEC |
| FS Development Holdings, LLC, Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC, James Tananbaum ×3 başvurular | 05 Ocak 2023 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 31 içeriden öğrenenler · 13 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| John D Quisel | Chief Executive Officer | 15 Eylül 2026 M | 262.064 | 0 | 14 | $-12.028.932 |
| Jason Patrick Meyenburg | Chief Executive Officer | 03 Ocak 2022 A | 13.000 | 0 | 0 | $0 |
| Jean M. Franchi | Chief Financial Officer | 14 Nisan 2026 S | 64.333 | 0 | 6 | $-1.204.945 |
| Joanne Bryce | Chief Financial Officer | 10 Ocak 2024 A | 23.665 | 0 | 0 | $0 |
| Brian Piekos | CFO | 31 Mayıs 2022 A | 17.615 | 0 | 0 | $0 |
| Jonathan Yen-Wen Yu | Chief Operating Officer | 25 Ağustos 2026 M | 54.324 | 0 | 13 | $-5.589.011 |
| William Jacob Savage | Chief Medical Officer | 13 Nisan 2026 S | 79.480 | 0 | 8 | $-2.265.589 |
| Pamela Stephenson | Chief Commercial Officer | 17 Şubat 2026 S | 80.998 | 0 | 1 | $-347.679 |
| Brian Richard Macdonald | Chief Innovation Officer | 30 Haziran 2023 S | 12.276 | 0 | 0 | $0 |
| Walter Strapps | Chief Scientific Officer | 29 Nisan 2021 A | · | 0 | 0 | $0 |
| Samuel B. Barone | Chief Medical Officer | 12 Nisan 2021 A | · | 0 | 0 | $0 |
| Marc Uknis | Chief Medical Officer | 05 Şubat 2021 A | · | 0 | 0 | $0 |
| Scott Lauder | Chief Technology Officer | 05 Şubat 2021 A | · | 0 | 0 | $0 |
| Kevin Bitterman | Yönetim kurulu üyesi | 11 Eylül 2026 M | 0 | 0 | 62 | $-37.690.863 |
| Donald William Nicholson | Yönetim kurulu üyesi | 18 Haziran 2026 A | · | 0 | 0 | $0 |
| William Richard White | Yönetim kurulu üyesi | 18 Haziran 2026 A | 0 | 0 | 0 | $0 |
| Mark Chin | Yönetim kurulu üyesi | 18 Haziran 2026 A | · | 0 | 0 | $0 |
| Nadim Ahmed | Yönetim kurulu üyesi | 18 Haziran 2026 A | · | 0 | 0 | $0 |
| Liam Ratcliffe | Yönetim kurulu üyesi | 18 Haziran 2026 A | · | 0 | 0 | $0 |
| Georges Gemayel | Yönetim kurulu üyesi | 18 Haziran 2026 A | · | 0 | 0 | $0 |
| Mona Ashiya | Yönetim kurulu üyesi | 11 Haziran 2025 A | 186.541 | 0 | 0 | $0 |
| Jay T. Backstrom | Yönetim kurulu üyesi | 29 Aralık 2022 A | · | 0 | 0 | $0 |
| Tuyen Ong | Yönetim kurulu üyesi | 04 Ekim 2021 A | · | 0 | 0 | $0 |
| James B. Tananbaum | Yönetim kurulu üyesi | 04 Ekim 2021 A | · | 0 | 0 | $0 |
| Jason P Rhodes | Yönetim kurulu üyesi | 04 Ekim 2021 A | · | 0 | 0 | $0 |
| GORDON CARL L | Yönetim kurulu üyesi | 04 Ekim 2021 A | · | 0 | 0 | $0 |
| David Charles Lubner | Yönetim kurulu üyesi | 12 Mart 2021 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | 10% sahip | 28 Haziran 2023 S | 1.090.772 | 0 | 0 | $0 |
| Leonard Braden Michael | 10% sahip | 26 Ekim 2022 S | 247.500 | 0 | 0 | $0 |
| Rahul Khara | · | 06 Ağustos 2026 M | 52.324 | 0 | 11 | $-1.874.683 |
| Precillia Redmond | · | 05 Şubat 2021 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 35 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 4.571 NS | 31 Temmuz 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,72% | 40.535 SH | 01 Ekim 2026 | Günlük |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,51% | 600 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,51% | 32.477 NS | 31 Temmuz 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,17% | 2.728 SH | 01 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,15% | 211.840 SH | 11 Eylül 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,14% | 444 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,14% | 264.829 SH | 11 Eylül 2026 | Günlük |
| FFSM · FIDELITY COVINGTON TRUST | 0,12% | 23.639 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 30.333 SH | 19 Ağustos 2026 | Günlük |
| ESSC · Strategy Shares | 0,11% | 511 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 9.517 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,09% | 1.038 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,09% | 11.064 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,07% | 13.544 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 726.106 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,06% | 119.817 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 162.749 SH | 19 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,06% | 20.861 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 11.895 SH | 19 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 366.845 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 74.680 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 11.949 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 8.803 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 1.429 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,01% | 83.295 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.161 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 8.580 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 49.443 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 8.460 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 7.860 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 334 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 971.123 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.280 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 1.550 SH | 11 Eylül 2026 | Günlük |
IRON Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 19 analist
AL
Medyan hedef
$100.00
+55,0%
7 36,8%
Güçlü Al
11 57,9%
Al
1 5,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
12 analist · 2026-10-03Ortalama hedef $103.17 +59,9%
← Tüm hedeflerin altında
Mevcut fiyat $64.51
Düşük$83.00
Ortalama$103.17
Yüksek$128.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 30, 2026